nodes	percent_of_prediction	percent_of_DWPC	metapath
Lumiracoxib—PTGS2—urinary bladder cancer	0.51	1	CbGaD
Lumiracoxib—PTGS2—Cisplatin—urinary bladder cancer	0.0741	0.229	CbGbCtD
Lumiracoxib—PTGS2—Etoposide—urinary bladder cancer	0.0728	0.225	CbGbCtD
Lumiracoxib—PTGS1—Etoposide—urinary bladder cancer	0.0615	0.19	CbGbCtD
Lumiracoxib—CYP1A2—Fluorouracil—urinary bladder cancer	0.0329	0.102	CbGbCtD
Lumiracoxib—CYP2C9—Fluorouracil—urinary bladder cancer	0.0296	0.0916	CbGbCtD
Lumiracoxib—CYP1A2—Etoposide—urinary bladder cancer	0.0275	0.0849	CbGbCtD
Lumiracoxib—CYP2C9—Cisplatin—urinary bladder cancer	0.0252	0.0778	CbGbCtD
Lumiracoxib—CYP2C19—urine—urinary bladder cancer	0.00467	0.152	CbGeAlD
Lumiracoxib—CYP1A2—urine—urinary bladder cancer	0.00381	0.124	CbGeAlD
Lumiracoxib—CYP2C9—urine—urinary bladder cancer	0.00362	0.118	CbGeAlD
Lumiracoxib—UGT1A9—renal system—urinary bladder cancer	0.00307	0.0999	CbGeAlD
Lumiracoxib—Tolmetin—CXCL8—urinary bladder cancer	0.00199	0.213	CrCbGaD
Lumiracoxib—Diclofenac—UGT2B7—urinary bladder cancer	0.00194	0.207	CrCbGaD
Lumiracoxib—Tolmetin—MPO—urinary bladder cancer	0.00155	0.166	CrCbGaD
Lumiracoxib—PTGS1—prostate gland—urinary bladder cancer	0.00119	0.0386	CbGeAlD
Lumiracoxib—PTGS2—prostate gland—urinary bladder cancer	0.00113	0.0369	CbGeAlD
Lumiracoxib—Diclofenac—CXCL8—urinary bladder cancer	0.0011	0.117	CrCbGaD
Lumiracoxib—PTGS1—seminal vesicle—urinary bladder cancer	0.001	0.0326	CbGeAlD
Lumiracoxib—PTGS2—seminal vesicle—urinary bladder cancer	0.000959	0.0312	CbGeAlD
Lumiracoxib—CYP1A2—renal system—urinary bladder cancer	0.000933	0.0303	CbGeAlD
Lumiracoxib—PTGS1—epithelium—urinary bladder cancer	0.000871	0.0283	CbGeAlD
Lumiracoxib—Bromfenac—PTGS2—urinary bladder cancer	0.000863	0.0923	CrCbGaD
Lumiracoxib—PTGS1—smooth muscle tissue—urinary bladder cancer	0.000839	0.0273	CbGeAlD
Lumiracoxib—PTGS2—epithelium—urinary bladder cancer	0.000833	0.0271	CbGeAlD
Lumiracoxib—CYP2C19—vagina—urinary bladder cancer	0.000827	0.0269	CbGeAlD
Lumiracoxib—PTGS1—renal system—urinary bladder cancer	0.000808	0.0263	CbGeAlD
Lumiracoxib—PTGS2—smooth muscle tissue—urinary bladder cancer	0.000802	0.0261	CbGeAlD
Lumiracoxib—PTGS2—renal system—urinary bladder cancer	0.000772	0.0251	CbGeAlD
Lumiracoxib—PTGS2—urethra—urinary bladder cancer	0.000759	0.0247	CbGeAlD
Lumiracoxib—CYP2C9—female reproductive system—urinary bladder cancer	0.000709	0.0231	CbGeAlD
Lumiracoxib—PTGS1—female reproductive system—urinary bladder cancer	0.000647	0.021	CbGeAlD
Lumiracoxib—PTGS2—female reproductive system—urinary bladder cancer	0.000619	0.0201	CbGeAlD
Lumiracoxib—PTGS1—vagina—urinary bladder cancer	0.000585	0.019	CbGeAlD
Lumiracoxib—Tolmetin—PTGS2—urinary bladder cancer	0.00058	0.0621	CrCbGaD
Lumiracoxib—Meclofenamic acid—PTGS2—urinary bladder cancer	0.000572	0.0612	CrCbGaD
Lumiracoxib—PTGS2—vagina—urinary bladder cancer	0.000559	0.0182	CbGeAlD
Lumiracoxib—Mefenamic acid—PTGS2—urinary bladder cancer	0.000445	0.0476	CrCbGaD
Lumiracoxib—PTGS1—lymph node—urinary bladder cancer	0.000379	0.0123	CbGeAlD
Lumiracoxib—PTGS2—lymph node—urinary bladder cancer	0.000362	0.0118	CbGeAlD
Lumiracoxib—Diclofenac—PTGS2—urinary bladder cancer	0.00032	0.0342	CrCbGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—IL2—urinary bladder cancer	8.77e-05	0.000691	CbGpPWpGaD
Lumiracoxib—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—urinary bladder cancer	8.68e-05	0.000683	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—CCND1—urinary bladder cancer	8.55e-05	0.000673	CbGpPWpGaD
Lumiracoxib—PTGS2—C-MYB transcription factor network—KRAS—urinary bladder cancer	8.32e-05	0.000655	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—MMP9—urinary bladder cancer	8.3e-05	0.000654	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—GSTZ1—urinary bladder cancer	8.28e-05	0.000652	CbGpPWpGaD
Lumiracoxib—CYP1A2—Aryl Hydrocarbon Receptor—MYC—urinary bladder cancer	8.25e-05	0.000649	CbGpPWpGaD
Lumiracoxib—CYP2C9—Biological oxidations—GSTM1—urinary bladder cancer	8.23e-05	0.000647	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	8.21e-05	0.000646	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—CYP4B1—urinary bladder cancer	8.14e-05	0.000641	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metapathway biotransformation—GSTM1—urinary bladder cancer	8.11e-05	0.000639	CbGpPWpGaD
Lumiracoxib—PTGS2—Selenium Micronutrient Network—TNF—urinary bladder cancer	8.08e-05	0.000636	CbGpPWpGaD
Lumiracoxib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—urinary bladder cancer	8.07e-05	0.000635	CbGpPWpGaD
Lumiracoxib—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—urinary bladder cancer	8.07e-05	0.000635	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—CREBBP—urinary bladder cancer	7.86e-05	0.000619	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—GSTO2—urinary bladder cancer	7.85e-05	0.000618	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—NAT1—urinary bladder cancer	7.85e-05	0.000618	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—urinary bladder cancer	7.77e-05	0.000611	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	7.72e-05	0.000608	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—SLC19A1—urinary bladder cancer	7.69e-05	0.000605	CbGpPWpGaD
Lumiracoxib—CYP1A2—Aryl Hydrocarbon Receptor—TNF—urinary bladder cancer	7.68e-05	0.000605	CbGpPWpGaD
Lumiracoxib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—urinary bladder cancer	7.68e-05	0.000605	CbGpPWpGaD
Lumiracoxib—CYP1A2—Biological oxidations—GSTP1—urinary bladder cancer	7.65e-05	0.000602	CbGpPWpGaD
Lumiracoxib—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—urinary bladder cancer	7.62e-05	0.0006	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metapathway biotransformation—GSTP1—urinary bladder cancer	7.54e-05	0.000594	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—PRSS3—urinary bladder cancer	7.49e-05	0.00059	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	7.37e-05	0.00058	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—TYMP—urinary bladder cancer	7.35e-05	0.000578	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—SLC19A1—urinary bladder cancer	7.29e-05	0.000574	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—UGT2B7—urinary bladder cancer	7.18e-05	0.000565	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—PRSS3—urinary bladder cancer	7.1e-05	0.000559	CbGpPWpGaD
Lumiracoxib—PTGS2—C-MYB transcription factor network—HRAS—urinary bladder cancer	7.07e-05	0.000557	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	7.06e-05	0.000556	CbGpPWpGaD
Lumiracoxib—CYP1A2—Biological oxidations—GSTM1—urinary bladder cancer	7.03e-05	0.000553	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metapathway biotransformation—GSTM1—urinary bladder cancer	6.93e-05	0.000546	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—MYC—urinary bladder cancer	6.86e-05	0.00054	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—HDAC4—urinary bladder cancer	6.78e-05	0.000533	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—EGFR—urinary bladder cancer	6.71e-05	0.000528	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—NAT2—urinary bladder cancer	6.65e-05	0.000523	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—urinary bladder cancer	6.59e-05	0.000518	CbGpPWpGaD
Lumiracoxib—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—urinary bladder cancer	6.48e-05	0.00051	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—CYP4B1—urinary bladder cancer	6.46e-05	0.000509	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—TNF—urinary bladder cancer	6.39e-05	0.000503	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—SLC19A1—urinary bladder cancer	6.1e-05	0.00048	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—GSTZ1—urinary bladder cancer	6.01e-05	0.000473	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	6.01e-05	0.000473	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—TYMP—urinary bladder cancer	5.99e-05	0.000472	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—PRSS3—urinary bladder cancer	5.95e-05	0.000468	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	5.82e-05	0.000458	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	5.75e-05	0.000453	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—RRM2—urinary bladder cancer	5.74e-05	0.000452	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—GSTO2—urinary bladder cancer	5.7e-05	0.000449	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—NAT1—urinary bladder cancer	5.7e-05	0.000449	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—TP53—urinary bladder cancer	5.63e-05	0.000443	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	5.63e-05	0.000443	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	5.62e-05	0.000442	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	5.61e-05	0.000441	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—GSTZ1—urinary bladder cancer	5.48e-05	0.000432	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—NAT2—urinary bladder cancer	5.42e-05	0.000426	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—LIG1—urinary bladder cancer	5.38e-05	0.000424	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	5.36e-05	0.000422	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—HPGDS—urinary bladder cancer	5.31e-05	0.000418	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—ENO2—urinary bladder cancer	5.31e-05	0.000418	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	5.28e-05	0.000416	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—UGT2B7—urinary bladder cancer	5.21e-05	0.00041	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	5.21e-05	0.00041	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—GSTO2—urinary bladder cancer	5.2e-05	0.000409	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—NAT1—urinary bladder cancer	5.2e-05	0.000409	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—GSTT1—urinary bladder cancer	5.15e-05	0.000406	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	5.11e-05	0.000402	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	5.07e-05	0.000399	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	4.77e-05	0.000375	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—TYMP—urinary bladder cancer	4.76e-05	0.000374	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—UGT2B7—urinary bladder cancer	4.75e-05	0.000374	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—CYP4B1—urinary bladder cancer	4.69e-05	0.000369	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—GSTZ1—urinary bladder cancer	4.69e-05	0.000369	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—RRM2—urinary bladder cancer	4.68e-05	0.000368	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	4.67e-05	0.000367	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	4.57e-05	0.00036	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	4.56e-05	0.000359	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—GSTO2—urinary bladder cancer	4.44e-05	0.00035	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—NAT1—urinary bladder cancer	4.44e-05	0.00035	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—SLC19A1—urinary bladder cancer	4.43e-05	0.000349	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	4.37e-05	0.000344	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	4.35e-05	0.000342	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—ENO2—urinary bladder cancer	4.33e-05	0.000341	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—HPGDS—urinary bladder cancer	4.33e-05	0.000341	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—PRSS3—urinary bladder cancer	4.32e-05	0.00034	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	4.31e-05	0.000339	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	4.31e-05	0.000339	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—NAT2—urinary bladder cancer	4.3e-05	0.000339	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—NQO1—urinary bladder cancer	4.28e-05	0.000337	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—CYP4B1—urinary bladder cancer	4.28e-05	0.000337	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—GSTT1—urinary bladder cancer	4.2e-05	0.000331	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	4.16e-05	0.000327	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	4.14e-05	0.000326	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—ENO2—urinary bladder cancer	4.11e-05	0.000323	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—UGT2B7—urinary bladder cancer	4.06e-05	0.00032	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—SLC19A1—urinary bladder cancer	4.04e-05	0.000318	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—PRSS3—urinary bladder cancer	3.94e-05	0.00031	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—RBX1—urinary bladder cancer	3.89e-05	0.000306	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	3.83e-05	0.000302	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—RRM2—urinary bladder cancer	3.71e-05	0.000292	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—CYP4B1—urinary bladder cancer	3.66e-05	0.000288	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	3.62e-05	0.000285	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—GSTP1—urinary bladder cancer	3.57e-05	0.000281	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—NQO1—urinary bladder cancer	3.49e-05	0.000275	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—JAG1—urinary bladder cancer	3.48e-05	0.000274	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	3.46e-05	0.000273	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	3.46e-05	0.000272	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—SLC19A1—urinary bladder cancer	3.45e-05	0.000272	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—TYMP—urinary bladder cancer	3.45e-05	0.000272	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—HPGDS—urinary bladder cancer	3.44e-05	0.000271	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—ENO2—urinary bladder cancer	3.44e-05	0.000271	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	3.42e-05	0.000269	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	3.39e-05	0.000267	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—PRSS3—urinary bladder cancer	3.37e-05	0.000265	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—GSTT1—urinary bladder cancer	3.33e-05	0.000262	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—TYMS—urinary bladder cancer	3.32e-05	0.000261	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	3.32e-05	0.000261	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	3.28e-05	0.000258	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—GSTM1—urinary bladder cancer	3.28e-05	0.000258	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—NCOR1—urinary bladder cancer	3.28e-05	0.000258	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	3.16e-05	0.000249	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—TYMP—urinary bladder cancer	3.15e-05	0.000248	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—GPX1—urinary bladder cancer	3.14e-05	0.000247	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—NAT2—urinary bladder cancer	3.12e-05	0.000246	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—ERCC2—urinary bladder cancer	3.09e-05	0.000243	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	3.02e-05	0.000238	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	2.95e-05	0.000232	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—GSTP1—urinary bladder cancer	2.91e-05	0.000229	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—MTHFR—urinary bladder cancer	2.9e-05	0.000228	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—NAT2—urinary bladder cancer	2.85e-05	0.000224	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	2.82e-05	0.000222	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—NQO1—urinary bladder cancer	2.77e-05	0.000218	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—TYMS—urinary bladder cancer	2.71e-05	0.000213	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	2.7e-05	0.000212	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—RRM2—urinary bladder cancer	2.7e-05	0.000212	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—TYMP—urinary bladder cancer	2.69e-05	0.000212	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—GSTM1—urinary bladder cancer	2.68e-05	0.000211	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—NCOR1—urinary bladder cancer	2.68e-05	0.000211	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	2.58e-05	0.000203	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—GPX1—urinary bladder cancer	2.56e-05	0.000202	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—NCOR1—urinary bladder cancer	2.54e-05	0.0002	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—ERCC2—urinary bladder cancer	2.52e-05	0.000198	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—ENO2—urinary bladder cancer	2.5e-05	0.000197	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—HPGDS—urinary bladder cancer	2.5e-05	0.000197	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	2.48e-05	0.000195	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—RRM2—urinary bladder cancer	2.46e-05	0.000194	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—NAT2—urinary bladder cancer	2.43e-05	0.000192	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—GSTT1—urinary bladder cancer	2.42e-05	0.000191	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	2.38e-05	0.000188	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—ERCC2—urinary bladder cancer	2.38e-05	0.000188	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—MTHFR—urinary bladder cancer	2.36e-05	0.000186	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—PPARG—urinary bladder cancer	2.35e-05	0.000185	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	2.34e-05	0.000185	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—GSTP1—urinary bladder cancer	2.31e-05	0.000182	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—HPGDS—urinary bladder cancer	2.28e-05	0.000179	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—ENO2—urinary bladder cancer	2.28e-05	0.000179	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	2.26e-05	0.000178	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—CREBBP—urinary bladder cancer	2.26e-05	0.000178	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—MTHFR—urinary bladder cancer	2.24e-05	0.000176	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	2.24e-05	0.000176	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—TERT—urinary bladder cancer	2.24e-05	0.000176	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—GSTT1—urinary bladder cancer	2.21e-05	0.000174	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	2.17e-05	0.000171	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—TYMS—urinary bladder cancer	2.15e-05	0.000169	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—NCOR1—urinary bladder cancer	2.12e-05	0.000167	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—GSTM1—urinary bladder cancer	2.12e-05	0.000167	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—RRM2—urinary bladder cancer	2.1e-05	0.000165	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—FGFR3—urinary bladder cancer	2.05e-05	0.000161	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—GPX1—urinary bladder cancer	2.03e-05	0.00016	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—NQO1—urinary bladder cancer	2.01e-05	0.000158	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—ERCC2—urinary bladder cancer	2e-05	0.000157	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.95e-05	0.000154	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—HPGDS—urinary bladder cancer	1.95e-05	0.000153	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—ENO2—urinary bladder cancer	1.95e-05	0.000153	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	1.93e-05	0.000152	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—PPARG—urinary bladder cancer	1.92e-05	0.000151	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—GSTT1—urinary bladder cancer	1.89e-05	0.000149	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—MTHFR—urinary bladder cancer	1.88e-05	0.000148	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.86e-05	0.000146	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—PTGS2—urinary bladder cancer	1.85e-05	0.000146	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—CREBBP—urinary bladder cancer	1.84e-05	0.000145	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—NQO1—urinary bladder cancer	1.84e-05	0.000144	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.78e-05	0.00014	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—CREBBP—urinary bladder cancer	1.75e-05	0.000137	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.7e-05	0.000134	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—GSTP1—urinary bladder cancer	1.68e-05	0.000132	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.62e-05	0.000128	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—PTEN—urinary bladder cancer	1.61e-05	0.000127	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—RHOA—urinary bladder cancer	1.58e-05	0.000124	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—NQO1—urinary bladder cancer	1.57e-05	0.000123	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—TYMS—urinary bladder cancer	1.56e-05	0.000123	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.55e-05	0.000122	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—GSTM1—urinary bladder cancer	1.54e-05	0.000121	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—NCOR1—urinary bladder cancer	1.54e-05	0.000121	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—EP300—urinary bladder cancer	1.54e-05	0.000121	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—GSTP1—urinary bladder cancer	1.53e-05	0.00012	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—PPARG—urinary bladder cancer	1.52e-05	0.00012	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.52e-05	0.00012	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—PTGS2—urinary bladder cancer	1.51e-05	0.000119	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.48e-05	0.000117	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—GPX1—urinary bladder cancer	1.48e-05	0.000116	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—CREBBP—urinary bladder cancer	1.46e-05	0.000115	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—ERBB2—urinary bladder cancer	1.46e-05	0.000115	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—ERCC2—urinary bladder cancer	1.45e-05	0.000114	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—TYMS—urinary bladder cancer	1.42e-05	0.000112	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—GSTM1—urinary bladder cancer	1.41e-05	0.000111	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—NCOR1—urinary bladder cancer	1.41e-05	0.000111	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—MTHFR—urinary bladder cancer	1.36e-05	0.000107	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—GPX1—urinary bladder cancer	1.35e-05	0.000106	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.33e-05	0.000104	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—ERCC2—urinary bladder cancer	1.32e-05	0.000104	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—PTEN—urinary bladder cancer	1.32e-05	0.000104	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—GSTP1—urinary bladder cancer	1.31e-05	0.000103	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.27e-05	9.96e-05	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—EP300—urinary bladder cancer	1.25e-05	9.87e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—CDKN1A—urinary bladder cancer	1.25e-05	9.84e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—PTEN—urinary bladder cancer	1.25e-05	9.81e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—MTHFR—urinary bladder cancer	1.24e-05	9.78e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—TYMS—urinary bladder cancer	1.22e-05	9.57e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—NCOR1—urinary bladder cancer	1.2e-05	9.46e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—GSTM1—urinary bladder cancer	1.2e-05	9.46e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—EP300—urinary bladder cancer	1.19e-05	9.36e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—SRC—urinary bladder cancer	1.16e-05	9.1e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—GPX1—urinary bladder cancer	1.15e-05	9.06e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—ERCC2—urinary bladder cancer	1.13e-05	8.9e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—PPARG—urinary bladder cancer	1.11e-05	8.7e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—MTHFR—urinary bladder cancer	1.06e-05	8.36e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—CREBBP—urinary bladder cancer	1.06e-05	8.36e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—PTEN—urinary bladder cancer	1.04e-05	8.22e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—MYC—urinary bladder cancer	1.04e-05	8.16e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—EGFR—urinary bladder cancer	1.01e-05	7.98e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—PPARG—urinary bladder cancer	1.01e-05	7.93e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—EP300—urinary bladder cancer	9.96e-06	7.84e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—CREBBP—urinary bladder cancer	9.68e-06	7.62e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—KRAS—urinary bladder cancer	9.58e-06	7.54e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—PTGS2—urinary bladder cancer	8.7e-06	6.85e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—PPARG—urinary bladder cancer	8.61e-06	6.78e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—CREBBP—urinary bladder cancer	8.28e-06	6.51e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—HRAS—urinary bladder cancer	8.14e-06	6.41e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—PTGS2—urinary bladder cancer	7.93e-06	6.24e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—PTEN—urinary bladder cancer	7.58e-06	5.97e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—EP300—urinary bladder cancer	7.23e-06	5.69e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—PTEN—urinary bladder cancer	6.92e-06	5.44e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—PTGS2—urinary bladder cancer	6.78e-06	5.33e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—EP300—urinary bladder cancer	6.6e-06	5.19e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—PTEN—urinary bladder cancer	5.91e-06	4.65e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—EP300—urinary bladder cancer	5.64e-06	4.44e-05	CbGpPWpGaD
